Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators..

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942
2.

Factors affecting willingness to practice medicine in underserved areas: a survey of Argentine medical students.

Borracci RA, Arribalzaga EB, Couto JL, Dvorkin M, Ahuad Guerrero RA, Fernandez C, Ferreira LN, Cerezo L.

Rural Remote Health. 2015 Oct-Dec;15(4):3485. Epub 2015 Dec 2.

3.

Mortality in low- and very low-risk patients undergoing cardiac surgery: evaluation according to the EuroSCORE II as a new standard.

Borracci RA, Rubio M, Baldi J Jr, Ahuad Guerrero RA, Mauro V.

Cardiol J. 2015;22(5):495-500. doi: 10.5603/CJ.a2015.0028. Epub 2015 May 25.

PMID:
26004937
4.

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.

Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Jansk√Ĺ P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators..

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20. doi: 10.1161/CIRCOUTCOMES.114.001556. Epub 2015 Feb 24.

5.

Prospective validation of EuroSCORE II in patients undergoing cardiac surgery in Argentinean centres.

Borracci RA, Rubio M, Celano L, Ingino CA, Allende NG, Ahuad Guerrero RA.

Interact Cardiovasc Thorac Surg. 2014 May;18(5):539-43. doi: 10.1093/icvts/ivt550. Epub 2014 Feb 2.

PMID:
24491683
6.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators..

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
7.

Irbesartan in patients with atrial fibrillation.

ACTIVE I Investigators., Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ.

N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.

8.

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.

Aronson D, Verbalis JG, Mueller M, Krum H; DILIPO investigators..

Eur J Heart Fail. 2011 Mar;13(3):327-36. doi: 10.1093/eurjhf/hfq226. Epub 2011 Jan 3.

9.

Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

ACTIVE Investigators., Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S.

N Engl J Med. 2009 May 14;360(20):2066-78. doi: 10.1056/NEJMoa0901301. Epub 2009 Mar 31.

10.

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Tardif JC, Ponikowski P, Kahan T; ASSOCIATE Study Investigators..

Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.

11.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators..

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
12.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators., Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
14.

Facilitated PCI in patients with ST-elevation myocardial infarction.

Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteufl T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators..

N Engl J Med. 2008 May 22;358(21):2205-17. doi: 10.1056/NEJMoa0706816.

15.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators., Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

16.

[Continuous monitoring of cardiac surgery quality indicators].

Borracci RA, Rubio M, Ahuad Guerrero RA, Barrero C, Mauro V, Fairman E.

Arch Cardiol Mex. 2007 Oct-Dec;77(4):275-83. Spanish.

PMID:
18361071
17.

[Intracardiac sewing needle in a women with autoaggressive behavior].

Borracci RA, Milani AP, Ahuad Guerrero RA.

Rev Esp Cardiol. 2005 Apr;58(4):456-7. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center